These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39400959)

  • 1. Integrated analysis of bulk and single-cell RNA-seq data reveals cell differentiation-related subtypes and a scoring system in bladder cancer.
    Li S; Zheng F; Wang Z; Xiong S; Zeng J; Xu S; Fu B; Liu X
    J Cell Mol Med; 2024 Oct; 28(19):e70111. PubMed ID: 39400959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing bladder cancer management: development of a prognostic model and personalized therapy.
    Huang X; Du G; Yang Y; Su P; Chen S; Cai C; Huang T; Zeng Y; Tao Y; Tian D; Zhang N
    Front Immunol; 2024; 15():1430792. PubMed ID: 39104534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer.
    Wang J; Tan Z; Huang Y; Li C; Zhan P; Wang H; Li H
    Aging (Albany NY); 2024 Jul; 16(14):11385-11408. PubMed ID: 39033778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive scRNA-seq analysis to identify new markers of M2 macrophages for predicting the prognosis of prostate cancer.
    Ou Y; Xia C; Ye C; Liu M; Jiang H; Zhu Y; Yang D
    Ann Med; 2024 Dec; 56(1):2398195. PubMed ID: 39221762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification.
    Liu R; Ma J; Zhang Y; Zhou Z
    Front Immunol; 2024; 15():1449251. PubMed ID: 39430746
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y
    Front Immunol; 2024; 15():1419126. PubMed ID: 39234248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer.
    Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y
    Front Immunol; 2021; 12():724541. PubMed ID: 34512654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals immune suppression subtypes and establishes a novel signature for determining the prognosis in lung adenocarcinoma.
    Mao S; Wang Y; Chao N; Zeng L; Zhang L
    Cell Oncol (Dordr); 2024 Oct; 47(5):1697-1713. PubMed ID: 38616208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
    Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
    Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted gene co-expression network analysis can sort cancer-associated fibroblast-specific markers promoting bladder cancer progression.
    Liu B; Zhan Y; Chen X; Hu X; Wu B; Pan S
    J Cell Physiol; 2021 Feb; 236(2):1321-1331. PubMed ID: 32657439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer.
    Zheng F; Wang Z; Li S; Xiong S; Yuan Y; Zeng J; Tan Y; Liu X; Xu S; Fu B
    Eur J Med Res; 2024 Jul; 29(1):393. PubMed ID: 39075554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.
    Liu R; Yang T; Huang J; Xiao Z; Liu J; Li Z; Tong S
    BMC Cancer; 2024 Aug; 24(1):947. PubMed ID: 39095785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated Genes in Bladder Cancer.
    Cao M; Cao Y; Xue S; Zhang Q; Zhang H; Xue W
    Altern Ther Health Med; 2024 Apr; 30(4):130-138. PubMed ID: 38518167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics of disulfidptosis and a prognostic signature in BLCA.
    Deng H; Cheng F; Cheng S
    Aging (Albany NY); 2024 Mar; 16(6):5751-5771. PubMed ID: 38507521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell and bulk RNA-sequence identified fibroblasts signature and CD8 + T-cell - fibroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics study.
    Li J; Kong Z; Qi Y; Wang W; Su Q; Huang W; Zhang Z; Li S; Du E
    Int J Surg; 2024 Aug; 110(8):4911-4931. PubMed ID: 38759695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer.
    Zhang W; Wang X; Dong J; Wang K; Jiang W; Fan C; Liu H; Fan L; Zhao L; Li G
    J Cell Mol Med; 2024 Jun; 28(12):e18373. PubMed ID: 38894657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer.
    Liu X; Qiu Z; Zhang X; Su Z; Yi R; Zou D; Xie C; Jin N; Long W; Liu X
    Environ Toxicol; 2024 Feb; 39(2):680-694. PubMed ID: 37647346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer.
    Fang Z; Han YL; Gao ZJ; Yao F
    Aging (Albany NY); 2024 May; 16(9):8279-8305. PubMed ID: 38728370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.